Elke Schueler
Sulzbach An Der Murr, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Heart failure outcomes and empagliflozin effects in patients with heart failure and reduced ejection fraction in sinus rhythm or atrial fibrillation: Data from EMPEROR-Reduced.
Journal: European journal of heart failure
Published: May 26, 2025
A Comparison of SGLT2 or DPP-4 Inhibitor Monotherapy vs Placebo for Type 2 Diabetes in Adolescents vs Young Adults.
Journal: Journal of the Endocrine Society
Published: February 20, 2025
Impact of Empagliflozin on Glomerular Hyperfiltration and Albuminuria in Youth with Type 2 Diabetes: Post Hoc Analysis of DINAMO.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: January 29, 2025
Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure: The EMPEROR Program.
Journal: Journal of the American College of Cardiology
Published: January 09, 2025
Safety of Empagliflozin: An Individual Participant-Level Data Meta-Analysis from Four Large Trials.
Journal: Advances in therapy
Published: March 04, 2024
Uric Acid and SGLT2 Inhibition With Empagliflozin in Heart Failure With Preserved Ejection Fraction: The EMPEROR-Preserved Trial.
Journal: JACC. Heart failure
Published: February 09, 2024
Impact of empagliflozin on insulin needs in patients with heart failure and diabetes: An EMPEROR-Pooled analysis.
Journal: Diabetes, obesity & metabolism
Published: December 21, 2023
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials.
Journal: European journal of heart failure
Published: September 20, 2023
Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved trial.
Journal: European journal of heart failure
Published: January 27, 2023
Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled.
Journal: JAMA cardiology
Published: September 21, 2022
Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR-Preserved trial.
Journal: European journal of heart failure
Published: August 16, 2022
Last Updated: 09/26/2026